Targeted Alpha Therapy Market Size, Share, Trends, Industry Analysis and Forecast, 2026-2035

Targeted Alpha Therapy Market by Type of Radionuclide (Ac-225, Ra-223, Pb-212 and Other Alpha-Emitting Radionuclides), Targeting Vector (Small-molecule Ligands, Peptides, Antibodies / Antibody-Derived Vectors, No Exogenous Vector / Physiologic Targeting and Other Targeting Vectors), Therapeutic Area (Prostate Cancer, Neuroendocrine Tumors, Hematological Malignancies and Other Solid Tumors), End User and Geography (North America, Europe, Asia-Pacific and Rest of the World)

  • Lowest Price Guaranteed

  • Pages
    237

  • Last Updated
    September 2026

  • View Count
    5556

Request Quote
Select License Type
License Price

USD 4,799

USD 6,999

USD 10,599

USD 17,999